TABLE 5.

FDB and non-FDB patients and effect of treatment on lipid levels.

Parameter	FDB	Baseline			Follow-up
		N	Mean ± SD	p	N	Mean ± SD	p	N	Diference (%)	p
LDL-C (mmol/L)	+	148	5.57 ± 1.46	p < 0.001	124	3.45 ± 0.24	p = 0.117	120	−37.7	p < 0.001
	−	812	6.61 ± 1.95		779	3.21 ± 1.60		754	−51.1
TC (mmol/L)	+	153	7.88 ± 1.58	p < 0.001	131	5.58 ± 1.37	p = 0.252	131	−30.3	p < 0.001
	−	840	9.09 ± 1.97		795	5.39 ± 1.72		795	−40.7
APOB (g/L)	+	85	1.53 ± 0.37	p < 0.001	43	1.13 ± 0.38	p = 0.448	26	−29.2	p = 0.023
	−	430	1.83 ± 0.56		255	1.07 ± 0.51		132	−40.7
TG (mmol/L)	+	152	1.40 ± 0.98	p < 0.001	131	1.07 ± 0.51	p < 0.001	130	−24.0	p = 0.251
	−	833	1.86 ± 1.17		795	1.42 ± 0.83		788	−24.4
HDL-C (mmol/L)	+	151	1.68 ± 0.47	p = 0.960	129	1.60 ± 0.46	p = 0.316	127	−5.9	p = 0.455
	−	831	1.68 ± 0.46		790	1.55 ± 0.47		781	−7.6
Lp(a) (g/L)	+	133	0.40 ± 0.45	p = 0.229	33	0.65 ± 0.62	p = 0.350	33	61.2	p < 0.001
	−	715	0.46 ± 0.60		217	0.54 ± 0.66		216	1.0

+, FDB; −, non-FDB; N – number of patients; SD, standard deviation; p, p-value.